Literature DB >> 16258206

Comparison of the clinical courses of the opticospinal and conventional forms of multiple sclerosis in Japan.

Manabu Osoegawa1, Masaaki Niino, Masahito Tanaka, Seiji Kikuchi, Hiroyuki Murai, Toshiyuki Fukazawa, Motozumi Minohara, Ryuji Miyagishi, Takayuki Taniwaki, Kunio Tashiro, Jun-Ichi Kira.   

Abstract

We evaluated the clinical courses of 216 patients with multiple sclerosis (MS) diagnosed according to the recommended diagnostic criteria of McDonald et al (10). Sixty-five patients clinically displaying selective involvement of the optic nerves and spinal cord were classified as opticospinal MS (OS-MS), while the other 151 showing disseminated involvement of the central nervous system were classified as conventional MS (C-MS). The disease duration did not differ significantly between the two subtypes (11.2 years vs. 11.5 years). In addition to a higher age of onset, female preponderance and higher Kurtzke's expanded disability status scale (EDSS) scores, the OS-MS patients showed a markedly lower frequency of secondary progressive MS than the C-MS patients (4.6% vs. 29.1%, p=0.0001). The EDSS scores of the C-MS patients were significantly correlated with the disease duration, while those of the OS-MS patients were not. Among the C-MS patients, the frequency of secondary progressive MS was significantly more common in patients with a disease duration of more than 10 years than in those with a shorter duration. These results suggest that the irreversible disability in OS-MS is determined by relapses, rather than by chronic progression, whereas C-MS has a similar clinical course to MS in Westerners.

Entities:  

Mesh:

Year:  2005        PMID: 16258206     DOI: 10.2169/internalmedicine.44.934

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Early relapse in multiple sclerosis-associated optic neuritis following the use of interferon beta-1a in Chinese patients.

Authors:  An-Guor Wang; Yen-Ching Lin; Shuu-Jiun Wang; Ching-Piao Tsai; May-Yung Yen
Journal:  Jpn J Ophthalmol       Date:  2006-12-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.